Close Menu
    Facebook X (Twitter) Instagram
    ScoopSquare24
    • Home
    • News
    • AI
    • Crypto
    • Finance
    • Stocks
    Facebook X (Twitter) Instagram
    ScoopSquare24
    Home»News»Stocks»Symbotic (SYM) Surges as Analyst Declares It the AI Automation Frontrunner
    Stocks

    Symbotic (SYM) Surges as Analyst Declares It the AI Automation Frontrunner

    Oli DaleBy Oli DaleApril 15, 2026No Comments4 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Key Takeaways

    • DA Davidson elevated Symbotic (SYM) to Buy from Neutral, increasing the price target from $57 to $70.
    • Shares opened with a gap, rising from $56.56 to $61.04 at the market open, later trading around $59.67.
    • The rating change followed DA Davidson’s attendance at MODEX, where analysts determined Symbotic maintains a technological edge in AI-driven automation.
    • First quarter fiscal 2026 revenue reached $630M, surpassing projections, though earnings per share of $0.02 fell short of the $0.08 consensus by 75%.
    • Company insiders have been net sellers over the past three months, disposing of 178,492 shares, with notable sales from the CTO and other executives.

    Shares of SYM experienced a significant gap higher on Tuesday following DA Davidson’s decision to upgrade the warehouse automation specialist to Buy while simultaneously raising the price objective to $70 from the previous $57 mark. The stock concluded the preceding trading day at $56.56 before launching at $61.04.


    SYM Stock Card
    Symbotic Inc., SYM

    The rating enhancement emerged after DA Davidson’s team attended the MODEX trade show held in Atlanta, where their analysts conducted private meetings with Symbotic’s Chief Technology Officer and investor relations personnel. The team also surveyed numerous competing automation providers exhibiting at the conference.

    According to the firm’s assessment, Symbotic demonstrated a distinct technological superiority in AI-powered automation compared to rivals present at the exhibition. This competitive advantage, analysts suggested, should enable reduced deployment timelines and accelerate the pace of acquiring new clients.

    DA Davidson subsequently revised its forward-looking estimates for Symbotic upward based on insights gained during the event. The firm emphasized the company’s robust revenue predictability and solid financial position, highlighting that Symbotic maintains a net cash position.

    The warehouse automation company’s shares have experienced substantial appreciation over the trailing twelve months — climbing approximately 172% — although the current price remains considerably below some of the more optimistic analyst targets circulating on Wall Street.

    Contrasting Financial Performance

    Symbotic’s latest quarterly financial results presented a study in contrasts. Top-line revenue for the first quarter of fiscal year 2026 totaled $629.99 million, exceeding the consensus estimate of $622.58 million and representing a 29.4% year-over-year expansion.

    However, bottom-line results disappointed significantly. The company delivered $0.02 in earnings per share compared to expectations of $0.08 — representing a substantial 75% shortfall. Net profit margin remains in negative territory at -0.45%, while return on equity stands at -1.88%.

    Wall Street analysts currently project Symbotic will generate $0.13 in full-year EPS. The equity presently trades at a P/E ratio of -596.79 and exhibits a beta of 2.10, characteristics consistent with its high-growth, elevated-volatility nature.

    Street Sentiment Remains Divided

    The analyst community has not reached unanimous agreement on SYM’s outlook. The overall consensus rating stands at Hold, with an average price target of $65.62, based on MarketBeat data.

    Currently, seven analysts maintain Buy recommendations on the stock. Six have assigned Hold ratings. Three analysts have issued Sell ratings, including Goldman Sachs, which reaffirmed its Sell stance with a $50 price objective in January. Needham holds the most aggressive target on Wall Street at $75, accompanying a Buy rating issued in February.

    KeyBanc similarly elevated SYM to Overweight from Sector Weight in recent months, establishing a $70 price target — a decision informed by discussions with the company’s Chief Financial Officer and Vice President of Investor Relations.

    Institutional investor behavior has been varied. ARK Investment Management expanded its position by 32.4% during the third quarter, while additional institutional players have initiated new holdings. Conversely, company insiders have been reducing their positions.

    Chief Technology Officer James Kuffner disposed of 3,669 shares in late February at $56.84 per share. Insider William Boyd III sold 5,115 shares on April 1st at $55.99 each. Collectively, company insiders have sold 178,492 shares valued at more than $10.3 million over the past ninety days.

    Insiders currently control 8.16% of the outstanding share base. The 50-day moving average is positioned at $53.63, while the 200-day moving average stands at $61.22.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Oli Dale
    • Website

    Related Posts

    Circle Internet (CRCL) Hit with Class Action Lawsuit Over $280M Drift Protocol Breach

    April 17, 2026

    JPMorgan Analysts Say CLARITY Act Could Pass Before Midterm Elections

    April 17, 2026

    Tom Lee Predicts Further Gains After April 2026 Market Records

    April 17, 2026
    Leave A Reply Cancel Reply

    Breaking News
    Blockonomi

    Crypto News Just Turned Bullish: Coinbase CEO Brian Armstrong Calls a $60,000 Bitcoin Bottom While DOGE Holders Move to Pepeto

    Blockonomi
    Jun 16, 2026 9:27 PM
    Parameter

    CervoMed (CRVO) Stock Soars 32% on $3 Million Director Purchase

    Parameter
    Jun 16, 2026 8:27 PM
    Blockonomi

    CervoMed (CRVO) Surges 32% as Director Purchases $3 Million in Shares

    Blockonomi
    Jun 16, 2026 8:24 PM
    Moneycheck

    CervoMed (CRVO) Surges 32% Following Director’s $3 Million Stock Purchase

    Moneycheck
    Jun 16, 2026 8:24 PM
    Parameter

    Moderna (MRNA) Stock Surges 9% Following Positive FDA Assessment of mRNA Flu Vaccine

    Parameter
    Jun 16, 2026 8:20 PM
    Blockonomi

    Moderna (MRNA) Stock Surges 9% Following Positive FDA Review of mRNA Flu Vaccine

    Blockonomi
    Jun 16, 2026 8:17 PM
    Moneycheck

    Moderna (MRNA) Stock Surges 9% After FDA Gives Positive Signal on mRNA Flu Vaccine

    Moneycheck
    Jun 16, 2026 8:17 PM
    Coincentral

    CervoMed (CRVO) Stock Jumps 32% After Director Buys $3M – Time to Buy?

    Coincentral
    Jun 16, 2026 8:14 PM
    Parameter

    Palantir (PLTR) Stock Drops 2% Despite Wolfe Research Upgrade from Underperform

    Parameter
    Jun 16, 2026 8:13 PM
    Blockonomi

    Palantir (PLTR) Stock Drops 2% Despite Wolfe Research Upgrade to Peer Perform

    Blockonomi
    Jun 16, 2026 8:10 PM
    Moneycheck

    Palantir (PLTR) Stock Drops 2% Despite Wolfe Research Upgrade to Peer Perform

    Moneycheck
    Jun 16, 2026 8:10 PM
    Coincentral

    Moderna (MRNA) Stock Jumps 9% as FDA Clears Key Hurdle for mRNA Flu Shot

    Coincentral
    Jun 16, 2026 8:06 PM
    Coincentral

    Palantir (PLTR) Stock Falls 2% Even After Getting a Wall Street Upgrade

    Coincentral
    Jun 16, 2026 8:01 PM
    Blockonomi

    Anchorage Digital Unlocks New SWEEP Infrastructure for Institutions

    Blockonomi
    Jun 16, 2026 7:16 PM
    Parameter

    Alphabet (GOOG) Stock: Rises as Google Expands Android 17 Parental Controls

    Parameter
    Jun 16, 2026 7:13 PM
    Facebook X (Twitter) Instagram Pinterest
    ScoopSquare24

    Copyright © 2013 - 2026 Kooc Media Ltd. All rights reserved. Registered Company No.05695741
    Our Sites: FlowPresets / GardenBeast / GolfMonster / Blockonomi / Money Check / CoinCentral / Parameter / Circlo / Computing.net

    Type above and press Enter to search. Press Esc to cancel.